Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$3.11B |
| 2 |
Amazon
AMZN
|
+$1.13B |
| 3 |
Microsoft
MSFT
|
+$972M |
| 4 |
NVIDIA
NVDA
|
+$894M |
| 5 |
Intel
INTC
|
+$766M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualcomm
QCOM
|
+$565M |
| 2 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$563M |
| 3 |
Phillips 66
PSX
|
+$507M |
| 4 |
Eli Lilly
LLY
|
+$345M |
| 5 |
Palo Alto Networks
PANW
|
+$334M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.17% |
| 2 | Financials | 9.79% |
| 3 | Consumer Discretionary | 8.06% |
| 4 | Healthcare | 7.69% |
| 5 | Communication Services | 6.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2826
CALL
Vertex Pharmaceuticals
VRTX
$123B
| $1.38M | ﹤0.01% |
3,300
+2,100
| +175% | +$888K |
|
2827
Ligand Pharmaceuticals
LGND
$6.06B
| $1.37M | ﹤0.01% |
18,788
-14,997
| -44% | -$1.11M |
|
2828
Newmark Group
NMRK
$2.77B
| $1.37M | ﹤0.01% |
123,671
-108,732
| -47% | -$1.14M |
|
2829
Schrodinger
SDGR
$1.23B
| $1.37M | ﹤0.01% |
50,771
-36,489
| -42% | -$1.02M |
|
2830
Travere Therapeutics
TVTX
$5.84B
| $1.37M | ﹤0.01% |
177,757
-209,052
| -54% | -$1.76M |
|
2831
Extreme Networks
EXTR
$3.43B
| $1.37M | ﹤0.01% |
118,418
-86,231
| -42% | -$1.18M |
|
2832
Marcus & Millichap
MMI
$1.18B
| $1.36M | ﹤0.01% |
39,779
-20,589
| -34% | -$754K |
|
2833
Sprinklr
CXM
$1.57B
| $1.36M | ﹤0.01% |
110,726
-83,282
| -43% | -$1.06M |
|
|
WBA
2834
CALL
DELISTED
Walgreens Boots Alliance
WBA
| $1.36M | ﹤0.01% |
62,500
-995,000
| -94% | -$22.1M |
|
2835
CALL
Autodesk
ADSK
$50.7B
| $1.35M | ﹤0.01% |
5,200
-32,600
| -86% | -$8.25M |
|
2836
Napco Security Technologies
NSSC
$1.44B
| $1.35M | ﹤0.01% |
33,700
-23,319
| -41% | -$915K |
|
|
CFB
2837
DELISTED
CrossFirst Bankshares, Inc. Common Stock
CFB
| $1.35M | ﹤0.01% |
97,694
-28,064
| -22% | -$375K |
|
|
UNIT
2838
Uniti Group
UNIT
$2.35B
| $1.35M | ﹤0.01% |
228,872
-213,548
| -48% | -$1.22M |
|
2839
Karyopharm Therapeutics
KPTI
$43.3M
| $1.35M | ﹤0.01% |
59,521
-5,150
| -8% | -$90.3K |
|
2840
CALL
Ford
F
$56.3B
| $1.35M | ﹤0.01% |
101,500
-794,500
| -89% | -$9.63M |
|
2841
Cellectar Biosciences
CLRB
$20.1M
| $1.35M | ﹤0.01% |
+11,273
| New | +$1.22M |
|
|
LTC
2842
LTC Properties
LTC
$1.98B
| $1.35M | ﹤0.01% |
41,380
-34,771
| -46% | -$1.11M |
|
2843
ACM Research
ACMR
$5.52B
| $1.34M | ﹤0.01% |
46,049
-98,403
| -68% | -$2.25M |
|
2844
Green Plains
GPRE
$1.15B
| $1.34M | ﹤0.01% |
58,032
-275,953
| -83% | -$6.04M |
|
2845
Amalgamated Financial
AMAL
$1.5B
| $1.34M | ﹤0.01% |
55,836
+9,248
| +20% | +$227K |
|
|
AMK
2846
DELISTED
AssetMark Financial Holdings, Inc.
AMK
| $1.33M | ﹤0.01% |
37,684
-12,407
| -25% | -$406K |
|
2847
PUT
Stanley Black & Decker
SWK
$15.6B
| $1.33M | ﹤0.01% |
13,600
-11,400
| -46% | -$1.05M |
|
2848
Oil States International
OIS
$502M
| $1.33M | ﹤0.01% |
215,247
+58,422
| +37% | +$349K |
|
2849
Harmonic Inc
HLIT
$1.3B
| $1.32M | ﹤0.01% |
98,523
-73,869
| -43% | -$943K |
|
2850
QCR Holdings
QCRH
$1.72B
| $1.32M | ﹤0.01% |
21,780
-11,064
| -34% | -$633K |
|
Similar funds
Barclays's Q1 2024 Portfolio in Review
As of Q1 2024, Barclays held 5,511 positions worth $288B, up 5.5% from $273B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Barclays's Q1 2024 filing shows 303 new, 1,218 increased, 2,942 reduced and 472 closed positions. Its largest new stake was Flutter Entertainment: 1,101,287 shares worth $217M. The largest sale was Qualcomm, an estimated $565M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 21% a quarter earlier, followed by Financials and Consumer Discretionary.
- Barclays's largest Q1 2024 buy was Flutter Entertainment: 1,101,287 shares worth $217M.
- Barclays added most to Apple in Q1 2024, an estimated $3.11B increase.
- Barclays's biggest Q1 2024 reduction was Qualcomm, cutting an estimated $565M.
- Barclays fully exited Splunk Inc in Q1 2024, selling an estimated $210M.
- Barclays's ten largest holdings make up 29% of its $288B portfolio in Q1 2024.
- Barclays opened 303 new positions and closed 472 in Q1 2024.
- Barclays's portfolio value rose 5.5% quarter-over-quarter to $288B.
Based on Barclays's 13F filing for Q1 2024, filed 15 May 2024.